The Journal of Bone and Joint Surgery (American). 2006;88:322-327.
doi:10.2106/JBJS.F.00203
© 2006 The Journal of Bone and Joint Surgery, Inc.
Percutaneous Autologous Bone-Marrow Grafting for Nonunions
Surgical Technique
Ph. Hernigou, MD1,
G. Mathieu, MD1,
A. Poignard, MD1,
O. Manicom, MD1,
F. Beaujean, MD1 and
H. Rouard, MD1
1 Service de Chirurgie Orthopédique, Hôpital Henri Mondor, 94010
Creteil, France. E-mail address for Ph. Hernigou:
philippe.hernigou{at}hmn.aphp.fr
Investigation performed at the Service de Chirurgie
Orthopédique, Hôpital Henri Mondor, Creteil, France
The original scientific article in which the surgical technique was
presented was published in JBJS Vol. 87-A, pp. 1430-1437, July 2005
The authors did not receive grants or outside funding in support of their
research for or preparation of this manuscript. They did not receive payments
or other benefits or a commitment or agreement to provide such benefits from a
commercial entity. No commercial entity paid or directed, or agreed to pay or
direct, any benefits to any research fund, foundation, educational
institution, or other charitable or nonprofit organization with which the
authors are affiliated or associated.
BACKGROUND:
Bone marrow aspirated from the iliac crest contains progenitor cells that
can be used to obtain bone-healing of nonunions. However, there is little
available information regarding the number and concentration of these cells
that are necessary to obtain bone repair. The purpose of this study was to
evaluate the number and concentration of progenitor cells that were
transplanted for the treatment of nonunion, the callus volume obtained after
the transplantation, and the clinical healing rate.
METHODS:
Marrow was aspirated from both anterior iliac crests, concentrated on a
cell separator, and then injected into sixty noninfected atrophic nonunions of
the tibia. Each nonunion received a relatively constant volume of 20
cm3 of concentrated bone marrow. The number of progenitor cells
that was transplanted was estimated by counting the fibroblast colony-forming
units. The volume of mineralized bone formation was determined by comparing
preoperative computerized tomography scans with scans performed four months
following the injection.
RESULTS:
The aspirates contained an average (and standard deviation) of 612 ±
134 progenitors/cm3 (range, 12 to 1224 progenitors/cm3)
before concentration and an average of 2579 ± 1121
progenitors/cm3 (range, 60 to 6120 progenitors/cm3)
after concentration. An average total of 51 x 103 fibroblast
colony-forming units was injected into each nonunion. Bone union was obtained
in fifty-three patients, and the bone marrow that had been injected into the
nonunions of those patients contained >1500 progenitors/cm3 and
an average total of 54,962 ± 17,431 progenitors. The concentration (634
± 187 progenitors/cm3) and the total number (19,324 ±
6843) of progenitors injected into the nonunion sites of the seven patients in
whom bone union was not obtained were both significantly lower (p = 0.001 and
p < 0.01, respectively) than those in the patients who obtained bone union.
The volume of the mineralized callus measured at four months on the
computerized tomography scans of the patients who had union ranged from 0.8 to
5.3 cm3 (mean, 3.1 cm3). There was a positive
correlation between the volume of mineralized callus at four months and the
number (p = 0.04) and concentration (p = 0.01) of fibroblast colony-forming
units in the graft. There was a negative correlation between the time needed
to obtain union and the concentration of fibroblast colony-forming units in
the graft (p = 0.04).
CONCLUSIONS:
Percutaneous autologous bone-marrow grafting is an effective and safe
method for the treatment of an atrophic tibial diaphyseal nonunion. However,
its efficacy appears to be related to the number of progenitors in the graft,
and the number of progenitors available in bone marrow aspirated from the
iliac crest appears to be less than optimal in the absence of
concentration.

CiteULike Connotea Del.icio.us Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. M. Novicoff, A. Manaswi, M. V. Hogan, S. M. Brubaker, W. M. Mihalko, and K. J. Saleh
Critical Analysis of the Evidence for Current Technologies in Bone-Healing and Repair
J. Bone Joint Surg. Am.,
February 1, 2008;
90(Supplement_1):
85 - 91.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Carofino and J. R. Lieberman
Gene Therapy Applications for Fracture-Healing
J. Bone Joint Surg. Am.,
February 1, 2008;
90(Supplement_1):
99 - 110.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|